Psoriatic Arthritis Clinical Trials

psoriatic arthritis clinical study

Compensation

Up to $2000

For Completed Study

Psoriatic Arthritis Clinical research study

Diagnosed With Psoriatic Arthritis?

Are you living with Psoriatic Arthritis and interested in advancing medical research? Participate in our clinical trial to help explore new treatment options while receiving compensation for your involvement.

Discover if you qualify, learn more about the trial process, and see how your participation can contribute to the future of Psoriatic Arthritis treatments. Sign up below to begin!

What is Psoriatic Arthritis?

Psoriatic Arthritis (PsA) is a long-term autoimmune disease that causes swelling, pain, and stiffness in the joints. PsA happens because the immune system mistakenly attacks healthy joints and is treated by a Rheumatologist or Dermatologist. It can affect any joint but most often targets the fingers, toes, lower back, knees, and ankles. It may also cause the fingers or toes to swell up like sausages. PsA often occurs in people who have Psoriasis, a skin condition that causes red, scaly patches and are usually the first symptoms patients notice. PsA is different from Osteoarthritis (OA), which is treated by an Orthopedic Doctor. Osteoarthritis (OA) is a “wear and tear” type of arthritis that develops as people get older or after joint injuries.

Red, scaly psoriasis plaques on a person's elbow and knee

are you interested in our clinical trial?

Psoriatic Arthritis Study Eligibility

You could be eligible to participate in one of these research studies if you meet the following criteria:

Psoriatic Arthritis Trial Eligibility Criteria

  • Age 18+

  • Have been diagnosed with Psoriasis or Psoriatic Arthritis, Active Psoriatic Disease Activity, Currently taking medications for Psoriatic Disease

TWo Convenient Tampa Bay locations

Study Locations

clearwater clinical research facility

Clearwater Facility

Enroll Now

2147 NE Coachman Road
Clearwater, FL 33765
727-466-0078

Tampa clinical research facility

Tampa Facility

Enroll Now

605 N. Howard Ave.
Tampa, FL 33606
813-870-1292

Indication: Psoriatic Arthritis

What To Know About Volunteering For Our Psoriatic Arthritis Clinical Trial

Joining a clinical trial is entirely voluntary, and you have the freedom to withdraw at any time. The process begins by finding a suitable trial, consulting with study doctors to determine eligibility, signing an informed consent form, completing necessary screening tests, and enrolling if you meet the requirements.

psoriatic arthritis clinical trial

Step 1:

Determine Eligibility

Sign up and check your eligibility to participate in the Psoriatic Arthritis clinical trial.

Paid psoriatic arthritis clinical research

Step 2:

Participate In The Study

If qualified for the study, participate in up to 20 office visits over 52 weeks.

psoriatic arthritis clinical research

Step 3:

Compensation For Time/Travel

All study-related care is provided at no cost, and compensation for time and travel may be available.

Why Participate in a Clinical Trial?

For those diagnosed with Psoriatic Arthritis, joining a clinical trial offers the chance to discover potential new treatments designed to help manage and reduce symptoms.

  • No insurance required for this treatment

  • No cost study related exams

  • The chance to explore innovative treatments that may offer greater effectiveness than traditional options.

  • Play a role in advancing medical breakthroughs for Psoriatic Arthritis.

Psoriatic Arthritis trial near me

Registered With The National Library of Medicine

These clinical trials are officially registered with the U.S. National Library of Medicine. You can view full study details, including eligibility and locations, at ClinicalTrials.gov under study number NCT06865105, NCT07223138, and NCT07286058.

want to learn more?

What is Psoriatic Arthritis (PsA)?

Psoriatic Arthritis (PsA) is a chronic autoimmune condition that affects both the skin and joints. It occurs when the immune system mistakenly attacks healthy cells and tissues, leading to inflammation in the joints and skin. PsA is often associated with psoriasis, a skin condition that causes red, scaly patches, but it can also occur in individuals without any noticeable skin symptoms.

  • PsA primarily affects the joints, causing symptoms such as:
  • Joint pain, stiffness, and swelling
  • Skin rashes and patches (psoriasis)
  • Nail changes, including pitting or separation from the nail bed
  • Swelling in fingers and toes (dactylitis)
  • Reduced range of motion in affected joints
  • Fatigue and general malaise

While there is no cure for PsA, there are effective treatments available to manage symptoms, reduce inflammation, and prevent further joint damage. These treatments often include medications to suppress the immune system and control skin symptoms, along with lifestyle modifications to support overall health.

More Detailed Information

Frequently Asked Questions

Psoriatic arthritis clinical trials at Clinical Research of West Florida are structured research studies designed to evaluate new therapies and treatment approaches for individuals with PsA. These trials are essential in advancing the understanding of psoriatic arthritis and improving treatment strategies for patients. During these trials, participants may be assigned to receive study medication, which is compared to a placebo or existing treatments in a double-blind, randomized format. This ensures unbiased results and enhances the overall integrity of the study.

Participants in psoriatic arthritis clinical trials can expect regular monitoring of their health, which may include physical examinations, lab tests, and assessments of joint function. Additionally, they will receive personalized care and support from a team of medical professionals specializing in arthritis and autoimmune diseases. This approach helps ensure that participants not only contribute to vital research but also gain valuable insights into managing their condition.

Current PsA clinical trials are investigating a range of therapies, including biologics, small molecules, and other novel agents aimed at reducing inflammation and preventing joint damage. These treatments are designed to target specific components of the immune system, improving the quality of life for individuals with moderate to severe PsA. By participating in these trials, patients have access to the latest advancements in PsA treatment.

Understanding Placebo-Controlled Studies in Psoriatic Arthritis Research

Placebo-controlled studies are an essential part of PsA clinical trials. One group of participants receives the experimental therapy, while another group is given a placebo. This study design helps researchers accurately assess the effectiveness of the new therapy. Understanding the role of placebos helps potential participants appreciate the scientific rigor behind the trial and the importance of their involvement in advancing PsA treatment.

Evaluating the Results of New Psoriatic Arthritis Therapies

The evaluation of new PsA therapies involves a thorough process of monitoring disease progression, joint function, and symptom relief. Researchers assess how well new treatments reduce inflammation, alleviate symptoms, and prevent long-term joint damage. By participating in these trials, patients play an essential role in determining which therapies may become part of the standard treatment for PsA.

Access to Innovative Treatments for Psoriatic Arthritis

One of the major benefits of participating in PsA clinical trials is access to cutting-edge treatments that are not yet widely available. Participants may have the opportunity to try new medications that could provide better relief from joint pain and inflammation, improving their overall quality of life.

Contributing to Psoriatic Arthritis Research

By participating in PsA clinical trials, individuals help advance our understanding of psoriatic arthritis and contribute to the development of more effective treatments. Their involvement could lead to better management options for others in the future.

Enhanced Clinical Care and Support

Participants in PsA clinical trials often receive comprehensive care and support from experienced medical professionals. This may include regular health assessments, treatment adjustments, and education on managing their condition. This close attention ensures that participants not only contribute to research but also receive high-quality care.

The Importance of Double-Blind Randomized Studies

Double-blind randomized studies are a critical aspect of PsA clinical trials. In this design, neither the participant nor the researcher knows which treatment the participant is receiving, ensuring unbiased results and more reliable data. This methodology helps establish the effectiveness and safety of new PsA therapies.

Ensuring Participant Safety and Tolerability During Trials

Safety is a top priority in PsA clinical trials. Researchers monitor participants closely to track any side effects or adverse reactions to the study medication. Regular check-ins and ongoing communication ensure that participants are safe and comfortable throughout the trial.

Adhering to Standard of Care in Psoriatic Arthritis Research

PsA clinical trials adhere to the standard of care for patients with psoriatic arthritis. This means that participants receive appropriate treatments, even if they are enrolled in a trial. This ensures that their health and well-being are prioritized while also contributing to important research.

psoriatic arthritis study questions

Psoriatic Arthritis Clinical Trial FAQs

Psoriatic arthritis (PsA) is a chronic autoimmune disease that causes inflammation in the joints and skin. It occurs when the immune system mistakenly attacks healthy tissues, leading to joint pain, stiffness, and swelling. PsA most often affects the fingers, toes, lower back, knees, and ankles, and can cause fingers or toes to swell like sausages (dactylitis). It commonly occurs in people with psoriasis, a skin condition causing red, scaly patches, though it can also develop without visible skin symptoms. Other common signs include nail pitting, reduced range of motion, and fatigue.

To be eligible for a psoriatic arthritis clinical trial at Clinical Research of West Florida, participants must be age 18 or older, have been diagnosed with psoriasis or psoriatic arthritis, have active psoriatic disease activity, and be currently taking medications for psoriatic disease. Final eligibility is confirmed through a screening visit with the study team at either the Clearwater or Tampa facility.

Yes, you may qualify. The CRWF psoriatic arthritis clinical trial enrolls participants who have been diagnosed with either psoriasis or psoriatic arthritis, provided they have active psoriatic disease activity and are currently taking medications for psoriatic disease. Many people with psoriasis develop PsA symptoms over time, and current research examines both conditions as part of the broader spectrum of psoriatic disease.

Participants in the CRWF psoriatic arthritis clinical trial may receive up to $2,000 in compensation for time and travel for completed study participation. Study-related care is provided at no cost and no health insurance is required to participate.

The CRWF psoriatic arthritis clinical trial involves up to 20 office visits over a study period of 52 weeks at the Clearwater or Tampa facility. Participation is entirely voluntary and participants may withdraw at any time. Participants continue to receive appropriate standard-of-care treatment throughout the study.

Psoriatic arthritis is an autoimmune disease in which the immune system attacks healthy joint and skin tissue, typically treated by a rheumatologist or dermatologist. Osteoarthritis is a ‘wear and tear’ form of arthritis that develops as cartilage breaks down over time, typically from age or joint injury, and is treated by an orthopedic doctor. The two conditions have different causes, treatments, and long-term management approaches, even though both cause joint pain and stiffness.

Current psoriatic arthritis clinical trials are investigating biologic therapies, small-molecule drugs, and other novel agents that target specific immune pathways driving inflammation in PsA. These investigational treatments aim to reduce joint pain and swelling, slow or prevent joint damage, improve psoriasis-related skin symptoms, and improve long-term quality of life for people whose psoriatic disease is not fully controlled by current medications.

Yes. CRWF is currently conducting three psoriatic arthritis clinical trials officially registered with the U.S. National Library of Medicine on ClinicalTrials.gov under study numbers NCT06865105, NCT07223138, and NCT07286058. Participants can view full study details, eligibility, and locations on the ClinicalTrials.gov website.

To enroll in a psoriatic arthritis clinical trial in Tampa Bay, contact Clinical Research of West Florida at 727-466-0078 (Clearwater) or 813-870-1292 (Tampa), or complete the online eligibility form on this page. The study team will review your medical history, confirm eligibility based on your psoriasis or PsA diagnosis, and schedule a screening visit at the location most convenient for you.

Related reading: Psoriatic Arthritis Treatment Clinical Trials and How to Find Arthritis Clinical Trials Near You.

Interested In Learning More

Enroll Now